Control Bionics Limited (ASX:CBL)
Australia · Delayed Price · Currency is AUD 0.0590
-0.0010 (-1.67%)
At close: Feb 5, 2026
Control Bionics Revenue
In the fiscal year ending June 30, 2025, Control Bionics had annual revenue of 6.14M AUD with 14.84% growth. Control Bionics had revenue of 3.25M in the half year ending June 30, 2025, with 18.41% growth.
Revenue
6.14M
Revenue Growth
+14.84%
P/S Ratio
3.87
Revenue / Employee
n/a
Employees
n/a
Market Cap
23.81M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Jun 30, 2025 | 6.14M | 794.13K | 14.84% |
| Jun 30, 2024 | 5.35M | -291.61K | -5.17% |
| Jun 30, 2023 | 5.64M | 1.14M | 25.33% |
| Jun 30, 2022 | 4.50M | 413.43K | 10.11% |
| Jun 30, 2021 | 4.09M | 886.39K | 27.68% |
| Jun 30, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Nova Eye Medical | 29.27M |
| CleanSpace Holdings | 19.76M |
| Micro-X | 13.05M |
| ImpediMed | 12.72M |
| CurveBeam AI | 12.10M |
| CONNEQT Health | 6.05M |
| Atomo Diagnostics | 3.79M |
| OncoSil Medical | 1.54M |